BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23336727)

  • 1. Frequency and factors associated with adherence to and completion of combination antiretroviral therapy for prevention of mother to child transmission in western Kenya.
    Ayuo P; Musick B; Liu H; Braitstein P; Nyandiko W; Otieno-Nyunya B; Gardner A; Wools-Kaloustian K
    J Int AIDS Soc; 2013 Jan; 16(1):17994. PubMed ID: 23336727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of HIV-exposed children in western Kenya: efficacy of prevention of mother to child transmission in a resource-constrained setting.
    Nyandiko WM; Otieno-Nyunya B; Musick B; Bucher-Yiannoutsos S; Akhaabi P; Lane K; Yiannoutsos CT; Wools-Kaloustian K
    J Acquir Immune Defic Syndr; 2010 May; 54(1):42-50. PubMed ID: 20224420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disengagement of HIV-positive pregnant and postpartum women from antiretroviral therapy services: a cohort study.
    Phillips T; Thebus E; Bekker LG; Mcintyre J; Abrams EJ; Myer L
    J Int AIDS Soc; 2014; 17(1):19242. PubMed ID: 25301494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation and Operational Research: Integration of PMTCT and Antenatal Services Improves Combination Antiretroviral Therapy Uptake for HIV-Positive Pregnant Women in Southern Zambia: A Prototype for Option B+?
    Herlihy JM; Hamomba L; Bonawitz R; Goggin CE; Sambambi K; Mwale J; Musonda V; Musokatwane K; Hopkins KL; Semrau K; Hammond EE; Duncan J; Knapp AB; Thea DM
    J Acquir Immune Defic Syndr; 2015 Dec; 70(4):e123-9. PubMed ID: 26181813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes in a cohort of women who discontinued maternal triple-antiretroviral regimens initially used to prevent mother-to-child transmission during pregnancy and breastfeeding--Kenya, 2003-2009.
    Minniear TD; Girde S; Angira F; Mills LA; Zeh C; Peters PJ; Masaba R; Lando R; Thomas TK; Taylor AW;
    PLoS One; 2014; 9(4):e93556. PubMed ID: 24733021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of non-adherence to anti-retroviral therapy, the associated factors and infant outcomes among HIV-positive pregnant women: a prospective cohort study in Lesotho.
    Kadima N; Baldeh T; Thin K; Thabane L; Mbuagbaw L
    Pan Afr Med J; 2018; 30():239. PubMed ID: 30574258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of Option B and a fixed-dose combination antiretroviral regimen for prevention of mother-to-child transmission of HIV in South Africa: A model of uptake and adherence to care.
    Maskew M; Jamieson L; Mohomi G; Long L; Mongwenyana C; Nyoni C; Mokaba D; Fox MP; Sanne I; Rosen S
    PLoS One; 2018; 13(8):e0201955. PubMed ID: 30161147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of medication adherence and infant follow up in the prevention of mother to child HIV transmission programme in Addis Ababa: a cohort study.
    Mirkuzie AH; Hinderaker SG; Sisay MM; Moland KM; Mørkve O
    J Int AIDS Soc; 2011 Oct; 14():50. PubMed ID: 22017821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of prevention of mother to child transmission of the human immunodeficiency virus-1 in rural Kenya--a cohort study.
    Nduati EW; Hassan AS; Knight MG; Muema DM; Jahangir MN; Mwaringa SL; Etyang TJ; Rowland-Jones S; Urban BC; Berkley JA
    BMC Public Health; 2015 Oct; 15():1008. PubMed ID: 26433396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4, viral load response, and adherence among antiretroviral-naive breast-feeding women receiving triple antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV in Kisumu, Kenya.
    Okonji JA; Zeh C; Weidle PJ; Williamson J; Akoth B; Masaba RO; Fowler MG; Thomas TK
    J Acquir Immune Defic Syndr; 2012 Oct; 61(2):249-57. PubMed ID: 22692094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake and performance of prevention of mother-to-child transmission and early infant diagnosis in pregnant HIV-infected women and their exposed infants at seven health centres in Addis Ababa, Ethiopia.
    Girma M; Wendaferash R; Shibru H; Berhane Y; Hoelscher M; Kroidl A
    Trop Med Int Health; 2017 Jun; 22(6):765-775. PubMed ID: 28407452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission.
    Short CE; Douglas M; Smith JH; Taylor GP
    HIV Med; 2014 Apr; 15(4):233-8. PubMed ID: 24025074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of antiretroviral therapy in HIV-positive women ever enrolled into 'prevention of mother to child transmission' programme, Mandalay, Myanmar-a cohort study.
    Kyaw KWY; Satyanarayana S; Phyo KH; Kyaw NTT; Mon AA; Lwin TT; Aung TK; Oo MM; Aung ZZ; Htun T; Kham NSN; Mya T; Kumar AMV; Oo HN
    BMC Pregnancy Childbirth; 2018 Dec; 18(1):474. PubMed ID: 30514239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mother-baby dyads enrolled in PMTCT care in western Kenya: characteristics and implications for ART programmes.
    Ogalo EA; Adina JO; Ooko H; Batuka J; Kimaiyo S
    Afr J AIDS Res; 2018 Sep; 17(3):241-247. PubMed ID: 30319032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preconception use of cART by HIV-positive pregnant women increases the risk of infants being born small for gestational age.
    Snijdewind IJM; Smit C; Godfried MH; Bakker R; Nellen JFJB; Jaddoe VWV; van Leeuwen E; Reiss P; Steegers EAP; van der Ende ME
    PLoS One; 2018; 13(1):e0191389. PubMed ID: 29351561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse fetal and infant outcomes among HIV-infected women who received either nonnucleoside reverse transcriptase inhibitor-based or protease inhibitor-based antiretroviral therapy for prevention of mother-to-child transmission.
    Masaba R; Borkowf CB; Girde S; Zeh C; Ndivo R; Nyang'au I; Achola K; Thomas TK; Lecher SL
    AIDS; 2018 Jul; 32(12):1625-1632. PubMed ID: 30001243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of a PMTCT programme in rural Western Kenya.
    Azcoaga-Lorenzo A; Ferreyra C; Alvarez A; Palma PP; Velilla E; del Amo J
    AIDS Care; 2011 Mar; 23(3):274-80. PubMed ID: 21347890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated prevention of mother-to-child HIV transmission services, antiretroviral therapy initiation, and maternal and infant retention in care in rural north-central Nigeria: a cluster-randomised controlled trial.
    Aliyu MH; Blevins M; Audet CM; Kalish M; Gebi UI; Onwujekwe O; Lindegren ML; Shepherd BE; Wester CW; Vermund SH
    Lancet HIV; 2016 May; 3(5):e202-11. PubMed ID: 27126487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exclusive breastfeeding among women taking HAART for PMTCT of HIV-1 in the Kisumu Breastfeeding Study.
    Okanda JO; Borkowf CB; Girde S; Thomas TK; Lecher SL
    BMC Pediatr; 2014 Nov; 14():280. PubMed ID: 25380718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.